Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Ouallet

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Revue Neurologique|March 9, 2012
Recommendations for a definition of multiple sclerosis in support of early treatmentH Zéphir, E Bodiguel, C Bensa, et al.
Revue Neurologique|June 5, 2012
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosisC Bensa, E Bodiguel, D Brassat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal studyB Brochet, M S A Deloire, M Bonnet, et al.
AJNR. American Journal of Neuroradiology|November 8, 2014
MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3TA Crombé, M Saranathan, A Ruet, et al.
Revue Neurologique|February 14, 2012
Recommendations for useful serum testing with suspected multiple sclerosisJ-C Ouallet, E Bodiguel, C Bensa, et al.
Revue Neurologique|May 5, 2012
Recommendations for the management of multiple sclerosis relapsesD Laplaud, E Bodiguel, C Bensa, et al.
Neuropathology and Applied Neurobiology|November 26, 2003
Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt-Jakob diseaseA Favereaux, I Quadrio, A Perret-Liaudet, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Efficacy of rituximab in refractory neuromyelitis opticaN Collongues, D Brassat, E Maillart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2005
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosisM S A Deloire, E Salort, M Bonnet, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Revue Neurologique|March 9, 2012
Recommendations for a definition of multiple sclerosis in support of early treatmentH Zéphir, E Bodiguel, C Bensa, et al.
Revue Neurologique|June 5, 2012
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosisC Bensa, E Bodiguel, D Brassat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal studyB Brochet, M S A Deloire, M Bonnet, et al.
AJNR. American Journal of Neuroradiology|November 8, 2014
MS lesions are better detected with 3D T1 gradient-echo than with 2D T1 spin-echo gadolinium-enhanced imaging at 3TA Crombé, M Saranathan, A Ruet, et al.
Revue Neurologique|February 14, 2012
Recommendations for useful serum testing with suspected multiple sclerosisJ-C Ouallet, E Bodiguel, C Bensa, et al.
Revue Neurologique|May 5, 2012
Recommendations for the management of multiple sclerosis relapsesD Laplaud, E Bodiguel, C Bensa, et al.
Neuropathology and Applied Neurobiology|November 26, 2003
Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt-Jakob diseaseA Favereaux, I Quadrio, A Perret-Liaudet, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Efficacy of rituximab in refractory neuromyelitis opticaN Collongues, D Brassat, E Maillart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2005
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosisM S A Deloire, E Salort, M Bonnet, et al.
Pageof 3